Researchers normally employ several analytical instruments to assess complex cell-based assays. However, advanced flow cytometers can measure numerous parameters, such as cell viability, ...
When it comes to the laboratory workflow, researchers typically leverage the best attributes of multiple analytical instruments to evaluate complex cell-based assays. However, advanced flow cytometers ...
Much of what biologists know about the human immune system has been — quite literally — illuminated by flow cytometry. For more than 70 years, this technology has evolved to become one of immunology’s ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania to develop a ...
The discovery of novel immunotherapies that specifically target and enhance the T-cell response against cancer, for example CAR-T cells, bispecific antibodies and checkpoint inhibitors, is a rapidly ...
Cytek Biosciences, Inc. has launched the Cytek® Muse® Micro, an enhanced version of its original Guava® Muse® cell analyzer, aimed at making advanced cell analysis more accessible and affordable. The ...
Comprehensive digital guide to high-throughput screening (HTS) by cytometry, featuring assays, application data, and more Introduction to HTS cytometry and the all-in-one software solution for data ...
Since the 1950s, researchers have used a famous method invented by Wallace Coulter known as "flow cytometry" to characterize different types of immune cells in research studies and in blood samples ...
BD Biosciences in collaboration with Jamia Hamdard is all set to commence an online joint academic program ‘FACS eLEARN’ in flow cytometry for capacity development of professionals. BD-JH FACS Academy ...
The "U.S. Flow Cytometry Market Size, Share & Trends Analysis Report by Product (Software, Accessories), Technology (Cell-based, Bead-based), Application, End-use, Region, and Segment Forecasts, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results